Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Women Retain Insulin Sensitivity Better Than Men

By HospiMedica International staff writers
Posted on 05 Apr 2015
A new study shows that a protein that regulates muscle insulin resistance causes the sex differences in the risk of developing type two diabetes.

Researchers at McMaster University (Hamilton, ON, Canada) conducted a cross-sectional study of muscle biopsies in 34 women and 42 men to test for differences in the expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a protein that when active prevents insulin from signaling properly in muscle, reducing the amount of sugar uptake. More...
Real-time polymerase chain reaction (PCR) was performed to determine PTEN gene expression, and western blotting detected total and phosphorylated PTEN protein.

The results showed that while study participants were comparable in age and body mass index (BMI), women had higher adiposity (fat mass) than men for any given weight, as well as significant downregulation of PTEN gene expression and upregulation of PTEN protein phosphorylation (signifying inactivation), when compared to men. This remained true after correction for age, ethnicity, homeostatic model assessment insulin resistance (HOMA-IR), fat mass, and sex. The study was published in the March 2015 issue of Scientific Reports.

“This protein is one explanation of why women are relatively protected from type 2 diabetes, despite having more body fat content compared to men at a given weight,” said lead author pediatric endocrinologist M. Constantine Samaan, MD, an assistant professor of pediatrics at McMaster Children's Hospital. “Women's muscle appeared more efficient in neutralizing this protein, and this allows insulin to work better to move sugar from circulation to muscle.”

One of the hallmarks of obesity is the deposition of excess fat in and outside adipose tissue, with the increased adiposity associated with skeletal muscle insulin resistance. As skeletal muscle is the main organ responsible for postprandial glucose disposal, its insulin resistance is a major contributor to the global epidemic of type 2 diabetes. One of the factors that determine adiposity patterns is sex.

Related Links:

McMaster University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.